This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mcgill University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Ghada Ayoub: Innovator in Pharmaceutical Science
Introduction
Ghada Ayoub is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for pain management. Her work exemplifies the intersection of research and practical application in medicine.
Latest Patents
Ghada Ayoub holds a patent for "Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid and use thereof for treatment of pain." This patent discloses pharmaceutical salts and co-crystals that combine pentoxifylline, clonidine, and linsidomine with various acids. The method for preparing these compounds is also detailed, along with topical compositions that utilize these salts or co-crystals for effective pain treatment.
Career Highlights
Ghada Ayoub is affiliated with McGill University, where she continues her research and development in pharmaceutical sciences. Her academic and professional journey reflects her dedication to advancing medical treatments and improving patient outcomes.
Collaborations
Ghada has collaborated with notable colleagues, including Terence J. Coderre and André Laferrière. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving innovative breakthroughs.
Conclusion
Ghada Ayoub's contributions to pharmaceutical science, particularly in pain management, underscore her role as an influential inventor. Her patent and ongoing research at McGill University demonstrate her commitment to improving healthcare through innovation.